LATEST

• BUSINESS Leqembi Iqlik Autoinjector Now Available in US: Eisai/Biogen
  October 8, 2025

• BUSINESS Japan Ethical Drug Sales Edge Up 0.4% in August: Crecon
  October 8, 2025

• COMMENTARY Inside Eylea - 2: Will a Bio-AG Return after Six Years? Pricing Debate Resumes
  October 7, 2025

• ACADEMIA Japan’s Sakaguchi Wins 2025 Nobel Prize in Medicine
  October 7, 2025

• BUSINESS Pharma Industry Generally Welcomes New LDP Leader Takaichi
  October 7, 2025

• BUSINESS Boehringer Ingelheim Taps Marc Hasson to Lead Japan Operations
  October 7, 2025

• BUSINESS Chugai CEO Lauds Sakaguchi’s Nobel-Winning Work
  October 7, 2025

• REGULATORY Takaichi Vows Hospital Support via Extra Budget; MHLW Sees Boost for Funding Requests
  October 7, 2025

• BUSINESS Alfresa, Kidswell, and Others to Form JV for Biosimilar Production in Japan
  October 7, 2025

• BUSINESS Gilead Opens Japan Facility to Support CAR-T Delivery
  October 7, 2025

• BUSINESS Datroway Hits Key Goals in Global PIII Trial for TNBC: Daiichi Sankyo
  October 7, 2025

• BUSINESS SymBio Kicks Off Global PIII Trial of Brincidofovir in Europe
  October 7, 2025

• BUSINESS Keytruda Maintains No. 1 Spot for 24th Straight Month: Encise
  October 7, 2025

• COMMENTARY Inside Eylea - 1: Patent Issues Behind Differences in Biosimilar Indications for AMD and DME
  October 6, 2025

• REGULATORY Japan to Allow Vaccine Strain Changes Under PACMP Framework
  October 6, 2025

• ORGANIZATION NPhA Urges Pharmacies to Provide Accurate Info on Acetaminophen Use during Pregnancy
  October 6, 2025

• BUSINESS Takeda Pulls Plug on Cell Therapy Work after Strategy Review
  October 6, 2025

• ORGANIZATION Japan Patient Group Calls for Dupixent Approval in Ichthyosis
  October 6, 2025

• REGULATORY Japan Health Minister Mum on NIP Use of RSV Preventives for Children
  October 6, 2025

• BUSINESS LEO Pharma Begins Promotional Activities for Spevigo in Japan
  October 6, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• …
• Next ›
• 最終 »